Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
Fibrocell Science, Inc. (0000357097)
Standardized SEC financial data for Fibrocell Science, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000357097 · Pharmaceutical Preparations.
Return on equity
-107.5%
Free cash flow
-$12.9M
Current ratio
6.69×
EPS (diluted)
$-1.45
Ratios for fiscal year 2018, standardized from SEC filings.
Income statement
USD
FY2016
FY2017
FY2018
Revenue
$355K
$0
$0
Cost of revenue
$697K
$0
—
Gross profit
-$342K
$0
—
R&D expense
$8.4M
$6.5M
$6.0M
SG&A expense
$9.8M
$6.7M
$6.4M
Operating income
-$26.5M
-$19.0M
Standardized from Fibrocell Science, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.